Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Moderna has raised $50.0M in total funding. The most recent round was Grant. The last funding was announced in June 2026.
Moderna's investors include RA Capital Management, Wellington Management, HSG, Ares Management, Blackstone Life Sciences.
Moderna is headquartered in Cambridge, United States.
Moderna Therapeutics is a biotechnology company that develops medicines and vaccines based on messenger RNA (mRNA) technology.
Moderna is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Moderna — Funding & Investors." VCBacked, June 1, 2026, https://www.vcbacked.co/company/moderna. Accessed September 30, 2026.
VCBacked. (2026). Moderna — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/moderna
{{cite web |title=Moderna — Funding & Investors |url=https://www.vcbacked.co/company/moderna |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated